中国抗癌协会乳腺肿瘤整形外科整合诊治指南(精简版)

China Anti-Cancer Association guidelines for holistic integrative management of breast oncoplastic surgery (abridged version)

  • 摘要: 2020年中国乳腺癌发病率首次超越肺癌,成为发病率最高的恶性肿瘤。外科手术是治疗早期乳腺癌的主要方法。近年来,随着整合诊疗水平的提高以及乳腺外科领域高质量发展,结合肿瘤整形外科的理念与技术,将整形外科原则和技术用于乳腺肿瘤患者治疗,使切除与修复完美整合,在保证肿瘤学安全性的前提下尽可能恢复因手术遭到破坏的器官功能和外观是目前乳腺外科关注的热点问题。但此项技术在国内开展时间短,技术发展不均衡,亟须制定相关指南以确保技术实施规范化,在确保肿瘤学安全性前提下,减少并发症,改善美学效果。

     

    Abstract: In 2020, the incidence rate of breast cancer in China surpassed that of lung cancer for the first time and became the malignant tumor with the highest incidence rate. Surgery is the main method to treat early breast cancer. In recent years, with the improvement of integrated diagnosis and treatment level and the high-quality development of breast surgery, combining the concepts and technologies of oncoplastic surgery, applying plastic surgery principles and techniques to the treatment of breast cancer patients, achieving perfect integration of resection and repair, and restoring organ function and appearance damaged by surgery as much as possible while ensuring the safety of oncology, is currently a hot topic of concern in breast surgery. However, this technology has been developed in China for a short period of time and its development is uneven. It is urgent to develop relevant guidelines to ensure standardized implementation of the technology, reduce complications, and improve aesthetic effects while ensuring the safety of oncology.

     

/

返回文章
返回